Strategies for elective red blood cell transfusion

Comment

C Lenfant. Ann Intern Med. 1992.

. 1992 Sep 1;117(5):441; author reply 442.

No abstract available

Comment on

Practice strategies for elective red blood cell transfusion. American College of Physicians.
[No authors listed] [No authors listed] Ann Intern Med. 1992 Mar 1;116(5):403-6. doi: 10.7326/0003-4819-116-5-403. Ann Intern Med. 1992. PMID: 1472172 No abstract available.
Prudent strategies for elective red blood cell transfusion.
Welch HG, Meehan KR, Goodnough LT. Welch HG, et al. Ann Intern Med. 1992 Mar 1;116(5):393-402. doi: 10.7326/0003-4819-116-5-393. Ann Intern Med. 1992. PMID: 1736773 Review.

Strategies for elective red blood cell transfusion.
Faust RJ, Ellison N. Faust RJ, et al. Ann Intern Med. 1992 Sep 1;117(5):442. Ann Intern Med. 1992. PMID: 1503339 No abstract available.
Strategies for elective red blood cell transfusion.
Andrews J, Ivker-Goldstein C, Brandstetter RD. Andrews J, et al. Ann Intern Med. 1992 Sep 1;117(5):441; author reply 442. Ann Intern Med. 1992. PMID: 1503337 No abstract available.
Safety and efficacy of unmodified whole blood vs. buffy coat-depleted red cell concentrates in autologous transfusion of elective orthopaedic surgery patients.
Karger R, Stangenberg K, Hinrichs F, Griss P, Kretschmer V. Karger R, et al. Transfus Med. 2004 Oct;14(5):347-57. doi: 10.1111/j.0958-7578.2004.00526.x. Transfus Med. 2004. PMID: 15500454
Current status of transfusion triggers for red blood cell concentrates.
Hardy JF. Hardy JF. Transfus Apher Sci. 2004 Aug;31(1):55-66. doi: 10.1016/j.transci.2004.06.002. Transfus Apher Sci. 2004. PMID: 15294196 Review.
[Pathogen inactivation in labile blood products: transfusion safety and economic impact].
Cazenave JP. Cazenave JP. Bull Acad Natl Med. 2006 Jan;190(1):169-85; discussion 186-8. Bull Acad Natl Med. 2006. PMID: 16878453 Review. French.